Ricky Goldwasser
Stock Analyst at Morgan Stanley
(4.52)
# 315
Out of 4,415 analysts
169
Total ratings
66.06%
Success rate
12.89%
Average return
Main Sectors:
22 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACCD Accolade | Maintains: Equal-Weight | $13 → $12 | $7.36 | +63.04% | 12 | Apr 26, 2024 | |
DOCS Doximity | Maintains: Underweight | $25 | $24.01 | +4.12% | 6 | Apr 23, 2024 | |
LFST LifeStance Health Group | Reiterates: Overweight | $10 | $6.45 | +55.04% | 7 | Apr 22, 2024 | |
UNH UnitedHealth Group | Maintains: Overweight | $618 → $584 | $484.11 | +20.63% | 10 | Apr 5, 2024 | |
GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $6.97 | -21.09% | 7 | Nov 10, 2023 | |
CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $205 | $232.69 | -11.90% | 13 | Nov 10, 2023 | |
OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $17.36 | -56.80% | 6 | Aug 30, 2023 | |
ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $5.22 | +129.89% | 7 | Aug 30, 2023 | |
CNC Centene | Downgrades: Equal-Weight | $94 → $73 | $72.25 | +1.04% | 9 | Aug 30, 2023 | |
DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $137.55 | +5.42% | 11 | Aug 3, 2023 | |
LH Laboratory Corporation of America Holdings | Maintains: Overweight | $285 → $260 | $201.32 | +29.15% | 8 | Aug 3, 2023 | |
MOH Molina Healthcare | Reiterates: Overweight | $365 | $338.87 | +7.71% | 5 | Jul 14, 2023 | |
MCK McKesson | Maintains: Overweight | $403 → $420 | $531.10 | -20.92% | 11 | Jan 6, 2023 | |
AMWL American Well | Maintains: Overweight | $7 → $6 | $0.53 | +1,029.52% | 4 | Jan 6, 2023 | |
HUM Humana | Maintains: Overweight | $549 → $620 | $314.21 | +97.32% | 10 | Oct 31, 2022 | |
ELV Elevance Health | Maintains: Equal-Weight | $485 → $500 | $524.84 | -4.73% | 2 | Oct 21, 2022 | |
CVS CVS Health | Maintains: Overweight | $127 → $124 | $56.31 | +120.21% | 5 | Oct 11, 2022 | |
CI Cigna | Maintains: Overweight | $296 → $318 | $357.18 | -10.97% | 10 | Aug 17, 2022 | |
CAH Cardinal Health | Maintains: Overweight | $74 → $70 | $102.17 | -31.49% | 9 | Jul 14, 2022 | |
WBA Walgreens Boots Alliance | Maintains: Underweight | $43 → $39 | $17.34 | +124.91% | 12 | Jul 6, 2022 | |
CTLT Catalent | Maintains: Overweight | n/a | $56.00 | - | 2 | Feb 3, 2021 | |
IQV IQVIA Holdings | Maintains: Overweight | n/a | $232.94 | - | 3 | Mar 27, 2020 |
Accolade
Apr 26, 2024
Maintains: Equal-Weight
Price Target: $13 → $12
Current: $7.36
Upside: +63.04%
Doximity
Apr 23, 2024
Maintains: Underweight
Price Target: $25
Current: $24.01
Upside: +4.12%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.45
Upside: +55.04%
UnitedHealth Group
Apr 5, 2024
Maintains: Overweight
Price Target: $618 → $584
Current: $484.11
Upside: +20.63%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $6.97
Upside: -21.09%
Charles River Laboratories International
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $220 → $205
Current: $232.69
Upside: -11.90%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $17.36
Upside: -56.80%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $5.22
Upside: +129.89%
Centene
Aug 30, 2023
Downgrades: Equal-Weight
Price Target: $94 → $73
Current: $72.25
Upside: +1.04%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $137.55
Upside: +5.42%
Laboratory Corporation of America Holdings
Aug 3, 2023
Maintains: Overweight
Price Target: $285 → $260
Current: $201.32
Upside: +29.15%
Molina Healthcare
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $338.87
Upside: +7.71%
McKesson
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $531.10
Upside: -20.92%
American Well
Jan 6, 2023
Maintains: Overweight
Price Target: $7 → $6
Current: $0.53
Upside: +1,029.52%
Humana
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $314.21
Upside: +97.32%
Elevance Health
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $524.84
Upside: -4.73%
CVS Health
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $56.31
Upside: +120.21%
Cigna
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $357.18
Upside: -10.97%
Cardinal Health
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $102.17
Upside: -31.49%
Walgreens Boots Alliance
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $17.34
Upside: +124.91%
Catalent
Feb 3, 2021
Maintains: Overweight
Price Target: n/a
Current: $56.00
Upside: -
IQVIA Holdings
Mar 27, 2020
Maintains: Overweight
Price Target: n/a
Current: $232.94
Upside: -